Karen Potter focuses on patent preparation, prosecution, and strategic counselling for startup, emerging, and established life sciences and biotechnology companies. She advises clients in the development and management of comprehensive patent portfolios and helps identify and evaluate patentability, secure protections worldwide, ensure freedom to operate, and perform due diligence. Building on her technical expertise in cellular and molecular biology and immunology, she has experience managing and developing patent portfolios in the areas of cellular immunotherapies and protein therapeutics, including antibody and enzyme therapeutics, and their uses in cancer therapy, inflammation and other disease applications.